Eric S. Surrey

No ORCID on file · 89 papers in corpus
rct 2018
·doi:10.1097/01.aog.0000533583.86343.77

INTRODUCTION: Rescue analgesic use was evaluated in two phase 3 studies, wherein 6-months (M) of elagolix (an oral, non-peptide GnRH antagonist) treatment was associated with improved dysmenorrhea and nonmenstrual pelvic pain compared to pl…

qualitative 2018
Postgraduate medicine ·doi:10.1080/00325481.2018.1526623

OBJECTIVES: Diagnostic delay is common in endometriosis. There is an unmet need for a symptom-based, patient-completed screening tool to facilitate discussions between patients and physicians about potential endometriosis symptoms. The obje…

2018
·doi:10.1016/j.jmig.2018.09.090
rct 2018
Obstetrics and gynecology ·doi:10.1097/aog.0000000000002675

OBJECTIVE: To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain. METHODS: Elaris Endometriosis (EM)-III and -IV were exte…

2018
·doi:10.1097/01.aog.0000533299.54528.7c

INTRODUCTION: Long-term safety and efficacy of elagolix, an oral, non-peptide GnRH antagonist for the management of endometriosis-associated pain, was evaluated in two 6-month (M) extension studies (Elaris EM-III and IV) of the pivotal, 6M,…

observational 2018
Advances in therapy ·doi:10.1007/s12325-018-0667-3

INTRODUCTION: The prevalence of endometriosis and the need for treatment in the USA has led to the need to explore the contemporary cost burden associated with the disease. This retrospective cohort study compared direct and indirect health…

2018
·doi:10.1016/j.fertnstert.2018.07.254
observational 2018
Journal of women's health (2002) ·doi:10.1089/jwh.2017.6752

BACKGROUND: Women with uterine fibroids (UF) may undergo less invasive procedures than hysterectomy, including myomectomy, endometrial ablation (EA), and uterine artery embolization (UAE); however, long-term need for reintervention is not w…

observational 2018
Journal of women's health (2002) ·doi:10.1089/jwh.2017.6432

BACKGROUND: Endometriosis has been associated with higher rates of various chronic conditions, but its epidemiological data are fragmented and dated. We sought to compare the incidence of developing commonly occurring comorbidities among pa…

observational 2017
Advances in therapy ·doi:10.1007/s12325-017-0630-8

INTRODUCTION: We sought to characterize changes in healthcare spending associated with the onset of 22 endometriosis-related comorbidities. METHODS: Women aged 18-49 years with endometriosis (N = 180,278) were extracted from 2006-2015 de-i…

observational 2017
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2017.05.004

Prolonged gonadotrophin-releasing hormone agonist (GnRHa) administration before IVF with fresh embryo transfer to patients with endometriosis or aberrant endometrial integrin expression (-integrin) improves outcomes but may suppress ovarian…

2017
·doi:10.1016/j.fertnstert.2017.07.293
2017
·doi:10.1016/j.jmig.2017.08.078
observational 2017
Journal of managed care & specialty pharmacy ·doi:10.18553/jmcp.2017.23.7.745

BACKGROUND: Characterized by pain symptoms, endometriosis affects women's productivity in their prime working years. OBJECTIVE: To evaluate the effect of individual endometriosis symptoms on household chore and employment productivity as m…

rct 2017
·doi:10.1056/nejmoa1700089

Copyright © 2017 Massachusetts Medical Society. BACKGROUND Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Elagolix, an oral, nonpeptide, gonadotropin-releasing hormone (GnRH) antagonist, …

observational 2017
Advances in therapy ·doi:10.1007/s12325-017-0619-3

INTRODUCTION: Hysterectomy and laparoscopy are common surgical procedures used for the treatment of endometriosis. This study compares outcomes for women who received either procedure within the first year post initial surgery. METHODS: Th…

2016
·doi:10.1016/j.fertnstert.2016.07.796
2016
·doi:10.1016/j.fertnstert.2016.07.772
2016
·doi:10.1016/j.fertnstert.2016.07.775
2016
·doi:10.1016/j.fertnstert.2016.07.271
review 2015
BioMed research international ·doi:10.1155/2015/482959

The assisted reproductive technologies, particularly in vitro fertilization (IVF), represent the most efficient and successful means of overcoming infertility associated with endometriosis. Although older studies suggest that IVF outcomes a…

review 2014

Copyright © 2015 Eric S. Surrey.This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly …

review 2013
Seminars in reproductive medicine ·doi:10.1055/s-0032-1333481

In vitro fertilization (IVF) represents the most efficient means of overcoming endometriosis-related infertility. Compromised pelvic anatomy and a hostile peritoneal environment are bypassed. Despite the results of early trials, more contem…

review 2012
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719112438061

Gonadotropin-releasing hormone agonists (GnRHa) are an effective treatment of endometriosis-associated pelvic pain. The use of hormonal add-back therapy can alleviate the hypoestrogenic symptoms associated with GnRHa therapy, while preservi…

review 2011
·doi:10.1017/cbo9780511734755

Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice offers a collection of concise, practical review articles on cutting-edge topics within reproductive medicine. Each article presents a balanced view o…